• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Impax Laboratories Inc

+ Add to Watchlist

ILR:GR

18.465 EUR 0.240 1.32%

As of 13:49:39 ET on 08/22/2014.

Snapshot for Impax Laboratories Inc (ILR)

Open: 18.105 Day's Range: 18.105 - 18.480 Volume: 0
Previous Close: 18.225 52wk Range: 14.050 - 22.900 1-Yr Rtn: +20.21%

Stock Chart for ILR

No chart data available.
  • ILR:GR 18.465
  • 1D
  • 1M
  • 1Y
18.225
Interactive ILR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ILR

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 22.7844
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 1.0730
Est. PEG Ratio 0.8318
Market Cap (M EUR) 1,305.45
Shares Outstanding (M) 70.70
30 Day Average Volume 7
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/04/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ILR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ILR

Impax Laboratories, Inc. develops, manufactures, and markets both proprietary and multi-source pharmaceutical products utilizing its drug delivery technologies. The Company specializes in the development of niche and controlled release generics, as well as the development of branded products.

George Frederick Wilkinson "Fred"President/CEOCarole S Ben-MaimonPres:Global Pharmaceuticals
Michael J NestorPres:Impax PharmaceuticalsBryan M ReasonsSenior VP:Finance/CFO
More Company Profile & Key Executives for ILR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil